Rehabilitation Robots Market Size & Growth Forecast 2027–2036, By Segments (End-use, Type, Extremity), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Rehabilitation Robots Market size was over USD 597.9 million in 2026 and is likely to grow at a 14.44% CAGR between 2027 and 2036, surpassing USD 2.3 billion by 2036. The industry revenue for 2027 is calculated at USD 670.6 million.
Get more details on this report
Request Free Sample ReportRehabilitation Robots Market Intelligence Snapshot
Regional Market Dynamics
- North America captured a 47.81% share in 2026, supported by established healthcare infrastructure, wider deployment of robotic rehabilitation systems, and strong clinical readiness for robot-assisted therapy.
- Asia Pacific is forecast to grow at a 16.8% CAGR as healthcare investment increases, hospitals modernize rehabilitation services, and more providers integrate robotic therapy into treatment pathways.
Segment Momentum
- Hospitals and clinics held a 49.93% share in 2026 because they provide structured rehabilitation programs, trained medical staff, established treatment pathways, and consistent patient volumes that support regular robot utilization.
- Therapy Robots are the fastest-growing type segment as providers seek scalable, task-focused rehabilitation tools that deliver consistent, high-frequency therapy across diverse recovery needs.
Market Expansion Drivers
- Rising stroke cases and aging population increasing rehabilitation robotics demand.
- Advancements in exoskeleton robotics improving mobility restoration and therapy outcomes.
- Increasing healthcare spending enabling adoption of AI-enabled tele-rehabilitation systems.
Leading Market Participants
- Leading companies in the rehabilitation robots market include CYBERDYNE Inc. (Japan), ReWalk Robotics Ltd. (Israel), Hocoma AG (Switzerland), Ekso Bionics Holdings, Inc. (United States), Tyromotion GmbH (Austria), Fourier Intelligence Co., Ltd. (China), Rex Bionics Ltd. (New Zealand), Rehab-Robotics Company Limited (Hong Kong), BIONIK Laboratories Corp. (Canada), AlterG, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 597.9 million
- 2027 Estimated Market Size: USD 670.6 million.
- Projected Market Size: USD 2.3 billion by 2036
- Growth Forecast: 14.44% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals & Clinics (End-use) | Exoskeletons (Type) | Lower Body (Extremity)
- Emerging Opportunity Segment: Senior Care Facilities (End-use) | Therapy Robots (Type) | Upper Body (Extremity)
Market Growth Drivers and Industry Trends
Rising stroke cases and aging population increasing rehabilitation robotics demand
The growing prevalence of stroke-related disabilities and the expanding elderly population are creating a sustained need for rehabilitation services, supporting the rehabilitation robots market. Stroke survivors frequently require prolonged physical therapy to regain movement, balance, coordination, and functional independence, while age-related conditions can increase the need for assisted mobility and recovery programs. Rehabilitation robots can support repetitive, controlled, and personalized exercises, allowing therapists to deliver structured treatment while accommodating different levels of patient capability. The rising number of individuals requiring physical rehabilitation is therefore encouraging healthcare providers to evaluate robotic systems for neurological and mobility-focused therapy programs.
Advancements in exoskeleton robotics improving mobility restoration and therapy outcomes
Technological progress in robotic exoskeletons is enhancing the capabilities of the rehabilitation robots market by enabling more precise assistance during gait training and mobility exercises. Modern exoskeleton systems can provide controlled support around impaired joints, helping patients practice walking movements while therapists adjust assistance according to individual rehabilitation requirements. Improvements in sensors, actuation systems, motion control, and ergonomic design are also making these devices more responsive to patient movements and suitable for a broader range of rehabilitation settings. Enhanced control over movement patterns and therapy intensity can support repetitive training for patients recovering from neurological injuries or physical impairments.
Increasing healthcare spending enabling adoption of AI-enabled tele-rehabilitation systems
Higher healthcare expenditure and growing investment in technology-enabled care delivery are creating opportunities for the rehabilitation robots market, particularly through AI-supported and remotely supervised rehabilitation solutions. Artificial intelligence can assist in evaluating movement patterns, adapting exercise intensity, tracking patient progress, and generating individualized therapy programs based on rehabilitation performance. Tele-rehabilitation capabilities further allow patients to receive guided therapy outside conventional clinical environments, improving access for individuals who face mobility or geographic barriers. Integration of robotics with connected platforms, remote monitoring tools, and intelligent analytics can provide clinicians with continuous information on therapy adherence and functional improvement.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising stroke cases and aging population increasing rehabilitation robotics demand | 2.40% | High | North America, Europe, Asia Pacific | High | Near Term |
| Advancements in exoskeleton robotics improving mobility restoration and therapy outcomes | 2.20% | High | North America, Europe, Asia Pacific | High | Mid Term |
| Increasing healthcare spending enabling adoption of AI-enabled tele-rehabilitation systems | 2.00% | Moderate | North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the rehabilitation robots market with a 47.81% share in 2026, supported by advanced healthcare infrastructure, strong adoption of rehabilitation technologies, and increasing demand for technology-assisted recovery solutions. The region benefits from established rehabilitation centers, specialized clinical expertise, and substantial investment in medical robotics and assistive technologies. Rising awareness of the benefits of intensive and personalized rehabilitation is encouraging healthcare providers to incorporate robotic systems into physical therapy programs for neurological, orthopedic, and mobility-related conditions. Continued technological development in areas such as sensor-based movement tracking, adaptive therapy, and intelligent patient monitoring is further strengthening the role of rehabilitation robots in clinical care.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, rising healthcare expenditure, and increasing demand for rehabilitation services. A growing burden of neurological and musculoskeletal conditions is creating greater need for efficient rehabilitation solutions, particularly as healthcare systems seek to improve access to specialized therapy. Investments in hospitals and rehabilitation facilities, combined with increasing awareness of robotic-assisted treatment, are supporting technology adoption. Improvements in medical technology capabilities and the gradual integration of automation into clinical environments are also creating favorable conditions for rehabilitation robots to gain wider acceptance across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Rehabilitation SystemsGermany emphasizes technologically advanced rehabilitation robots designed for clinical precision and long-term therapeutic reliability. Healthcare providers increasingly adopt robotic-assisted rehabilitation solutions that integrate seamlessly with established medical workflows.
France 🇫🇷
Hospital Rehabilitation FocusFrance continues expanding the use of rehabilitation robots within hospitals and specialized therapy centers to improve patient recovery pathways. Market participants focus on clinically validated robotic systems that complement conventional rehabilitation practices.
Italy 🇮🇹
Therapy Modernization InitiativesItaly's rehabilitation robots market supports healthcare providers seeking advanced technologies that improve rehabilitation quality and operational efficiency. Clinical adoption is centered on robotic systems that assist therapists while enhancing patient engagement during recovery programs.
Japan 🇯🇵
Aging Care SolutionsJapan's rehabilitation robots market is closely aligned with the need for technologies that support mobility recovery and elderly care. Developers prioritize compact, patient-friendly robotic systems that improve rehabilitation effectiveness across hospitals and care facilities.
South Korea 🇰🇷
Smart Healthcare IntegrationSouth Korea combines rehabilitation robotics with digital healthcare infrastructure to enhance therapy delivery and patient monitoring. Companies emphasize intelligent robotic platforms capable of supporting personalized rehabilitation programs and data-driven clinical decision-making.
United States 🇺🇸
Clinical Technology AdoptionThe U.S. rehabilitation robots market is driven by healthcare providers adopting robotic systems to improve therapy efficiency and patient outcomes. Companies focus on integrating robotics with digital monitoring platforms and evidence-based rehabilitation programs.
Segment Leadership and Growth Trends
Rehabilitation Robots Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Senior Care Facilities (Fastest-Growing Segment)
Hospitals & clinics accounted for the largest share of the rehabilitation robots market in 2026, with a 49.93% share, driven by their role as major centers for neurological, orthopedic, and post-acute rehabilitation services. These facilities have access to specialized rehabilitation professionals, advanced diagnostic capabilities, and structured therapy programs, enabling robotic systems to be integrated into supervised patient recovery. Rehabilitation robots can support repetitive and controlled movements while helping clinicians personalize therapy according to individual mobility needs. Growing emphasis on technology-assisted rehabilitation and improved functional outcomes is reinforcing adoption across hospital and clinical environments.
Senior care facilities are experiencing the fastest growth as aging populations increase demand for mobility assistance, physical rehabilitation, and supportive care for older adults. Rehabilitation robots can help these facilities provide structured therapy while reducing the physical burden associated with repetitive rehabilitation activities for caregivers. Their potential to support mobility, balance, strength, and functional independence is particularly relevant for elderly residents recovering from injury or managing age-related physical limitations. Increasing attention to maintaining quality of life and extending independent mobility is further encouraging the adoption of robotic rehabilitation technologies in senior care settings.
Type Segment Analysis: Exoskeletons (Largest Segment) vs Therapy Robots (Fastest-Growing Segment)
Exoskeletons held the largest share of the rehabilitation robots market in 2026, supported by their ability to provide direct physical assistance to individuals with impaired mobility. These wearable robotic systems can assist movement and gait training while enabling patients to participate more actively in rehabilitation exercises. Their application across neurological and mobility-related rehabilitation programs, combined with growing interest in restoring functional movement, has strengthened their importance within robotic rehabilitation. Continued improvements in robotic control, ergonomics, and patient-specific assistance are also supporting their clinical adoption.
Therapy robots represent the fastest-growing type as healthcare providers increasingly incorporate robotic assistance into structured rehabilitation programs. These systems can facilitate repetitive, precisely controlled exercises while allowing therapists to monitor and adjust treatment according to patient progress. Their usefulness in supporting consistent therapy sessions, improving treatment personalization, and reducing the physical workload associated with repetitive exercises is driving interest among rehabilitation providers. Growing emphasis on technology-enabled care and patient-centered recovery is expected to further support the segment's expansion.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals & Clinics, Senior Care Facilities, Homecare Settings | Hospitals & Clinics | Senior Care Facilities |
| Type | Therapy Robots, Exoskeletons | Exoskeletons | Therapy Robots |
| Extremity | Upper Body, Lower Body | Lower Body | Upper Body |
Competitive Landscape and Market Positioning
Major players in the rehabilitation robots market:
1. CYBERDYNE Inc. (Japan)
2. ReWalk Robotics Ltd. (Israel)
3. Hocoma AG (Switzerland)
4. Ekso Bionics Holdings Inc. (United States)
5. Tyromotion GmbH (Austria)
6. Fourier Intelligence Co. Ltd. (China)
7. Rex Bionics Ltd. (New Zealand)
8. Rehab-Robotics Company Limited (Hong Kong)
9. BIONIK Laboratories Corp. (Canada)
10. AlterG Inc. (United States)
The rehabilitation robots market is evolving rapidly with increasing integration of AI-enabled motion analysis, adaptive therapy systems, and robotic-assisted mobility solutions. Companies are focusing on enhancing patient recovery outcomes through personalized rehabilitation technologies and sensor-based monitoring capabilities. Continuous investment in advanced robotics research and remote rehabilitation platforms is further strengthening innovation across the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| CYBERDYNE Inc. (Japan) | |||||||
| ReWalk Robotics Ltd. (Israel) | |||||||
| Hocoma AG (Switzerland) | |||||||
| Ekso Bionics Holdings Inc. (United States) | |||||||
| Tyromotion GmbH (Austria) | |||||||
| Fourier Intelligence Co. Ltd. (China) | |||||||
| Rex Bionics Ltd. (New Zealand) | |||||||
| Rehab-Robotics Company Limited (Hong Kong) | |||||||
| BIONIK Laboratories Corp. (Canada) | |||||||
| AlterG Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Nanyang Technological University Singapore | Dec-24 | NTU Singapore partnered with Lions Befrienders, Smart Urban Co-Innovation Lab, and Lumens to deploy a robotic mobility initiative for seniors. This project integrates robotic assistance technology directly into community care environments, facilitating the real-world application of fall prevention and mobility-enhancing robotics for geriatric populations. |
| Southern Philippines Medical Center | Nov-24 | The Southern Philippines Medical Center launched a dedicated Robotics Neurorehabilitation and Musculoskeletal Rehabilitation facility. This investment marks a significant expansion in regional clinical capacity, creating new infrastructure for the deployment of robot-assisted therapy and demonstrating a move toward increased healthcare provider investment in automated rehabilitation technologies. |
| Fourier Intelligence | Nov-24 | Fourier Intelligence confirmed progress toward the mass production of its humanoid robots, signaling a shift toward large-scale commercialization. This operational advancement positions the company to address demand across healthcare and rehabilitation sectors, moving beyond development and prototyping toward high-volume manufacturing of its assistive robotics portfolio. |
| Biomotum | Nov-24 | Biomotum advanced the development of its lightweight ankle exoskeleton technology designed for joint assistance and resistance. The focus on mobility enhancement applications positions the company to address clinical needs for gait training, representing an incremental step in the commercial viability of wearable rehabilitation devices. |
| Curexo | Dec-23 | Curexo partnered with Motusium to facilitate the U.S. market expansion of its Morning Walk gait rehabilitation system. This strategic collaboration leverages Motusium's operational reach to increase the commercial footprint of Curexo’s robotic therapy solutions within North American clinical settings. |
| Bionik Laboratories | Sep-23 | Bionik Laboratories secured a U.S. patent for its upper-extremity rehabilitation technology. This intellectual property strengthens the company’s proprietary device and technique portfolio, providing a defensible foundation for the commercialization of its patient-positioning and guidance systems in clinical rehabilitation environments. |
| Harmonic Bionics | Apr-23 | Harmonic Bionics launched the Harmony SHR robotic rehabilitation system following successful FDA registration. The commercialization of this platform introduces a new technological capability for upper-extremity therapy, expanding the company's product portfolio and strengthening its competitive positioning in the specialized neurorehabilitation robotics segment. |
| Ekso Bionics Holdings, Inc. | Jan-22 | Ekso Bionics received 510(k) clearance from the U.S. FDA for the use of its EksoNR robotic exoskeleton in treating Multiple Sclerosis patients. This regulatory milestone expands the therapeutic indication for the company’s flagship device, providing a platform for broader clinical adoption and market penetration in MS rehabilitation. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Rehabilitation Robots Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Indication | Stroke Rehabilitation, Spinal Cord Injury Rehabilitation, Traumatic Brain Injury Rehabilitation, Orthopedic Rehabilitation, Neurological Rehabilitation |
| Purchase Model | Direct Equipment Purchase, Leasing, Equipment-as-a-Service, Pay-Per-Use |
| Patient Age Group | Pediatric, Adult, Geriatric |
Rehabilitation Robots Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption and Reimbursement Outlook |
|
| Care Delivery Workflow Integration Assessment |
|
| Emerging Service and Robot-as-a-Service Business Models |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the rehabilitation robots market?
What is the projected value of the rehabilitation robots industry by 2036?
How is rising clinical demand for scalable therapy influencing adoption of rehabilitation robots in healthcare facilities?
What is driving investment interest in AI-enabled tele-rehabilitation and advanced robotic systems in the rehabilitation robots market?
Why are hospitals and clinics the largest end-use segment in the rehabilitation robots market?
Which type segment is growing fastest in the rehabilitation robots market?
Why is North America the leading rehabilitation robots market?
What is accelerating rehabilitation robots market growth in Asia Pacific?
Who are the leading players in the rehabilitation robots landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization